All Stories

  1. Oncological outcomes and prognostic factors of pulmonary metastasectomy in pancreatic cancer
  2. Is Video-Assisted Thoracoscopic Surgery Still Ethically Defensible in the Era of Robotic-Assisted Thoracic Surgery?
  3. Anatomical Versus Non-Anatomical Pulmonary Metastasectomy: European Multicentre Analysis
  4. Novel Application of STRATOS for Restoration of Clavicular Stability After Oncologic Sternoclavicular Joint Resection: A Case Report and Review of the Literature
  5. Tumor biology versus nodal stage in predicting survival after resection of pulmonary atypical carcinoids
  6. 30-day postoperative mortality and the effects of hospital preparedness during the COVID-19 pandemic: a pooled analysis of prospective international cohort studies
  7. One needle, two diagnoses: a dual finding of adenocarcinoma and granulomatous reaction after EBUS-TBNA in lung cancer staging – a case report
  8. From Scalpel to Algorithms in Lung Cancer Management: Precision Requires Wisdom—Beware Not Artificial Intelligence, but Natural Stupidity
  9. Correction: Casiraghi et al. The Role of Incentive Respiratory Techniques in Enhanced Recovery After Lung Cancer Resection: A Propensity Score-Matched Study. J. Clin. Med. 2025, 14, 100
  10. The Immune Cost of the Thymus: Navigating Autoimmunity and Tumor Management in Thymic Epithelial Tumors
  11. Predictors of Loco-Regional Recurrence After Pulmonary Non-Anatomical Metastasectomy: A Multicentre Retrospective Analysis
  12. Recurrent Malignant Pericardial Effusion Management: The Pericardio-Peritoneal Window
  13. Recommendations for the standardization and management of prolonged air leaks in lung surgery
  14. Artificial intelligence in NSCLC management for revolutionizing diagnosis, prognosis, and treatment optimization: A systematic review
  15. Characterizing the Learning Curve of ION Robotic Bronchoscopy
  16. Fast Track Pathway for Lung Cancer: The Integration of ION Robotic-Assisted Bronchoscopy With Robotic Thoracic Surgical Resection
  17. Utility of Three-dimensional Holographic workstation for preoperative simulation of complex congenital heart surgery
  18. From nonintubation to tubeless: redefining perioperative strategies in modern anesthesiology and thoracic surgery
  19. Letter Re: TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma: signal or noise?
  20. Diaphragmatic plication for diaphragmatic paralysis: A systematic review and meta-analysis of surgical outcomes
  21. Neoadjuvant Chemoimmunotherapy in Stage III Non–Small Cell Lung Cancer
  22. 239P Dual AI models for perioperative decision support in resectable NSCLC: A real-world cohort analysis
  23. 163eP AI-enhanced prediction of diagnostic failure in early-stage lung cancer: Preprocedural score for ION robotic bronchoscopy
  24. The Price of Consensus: Reviewer disagreement, Editorial Dynamics, and Impact in Thoracic Oncology Publishing
  25. Survival outcomes and prognostic factors in surgically resected lung carcinoids: A 25-year retrospective analysis
  26. Biological staging in early-stage non-small-cell lung cancer: molecular risk-guided adjuvant therapy
  27. Clinicopathological Features and Prognosis of Lung Adenocarcinoma Presenting as Ground-Glass Opacity: A Single-Center Experience
  28. Broadening the evidence base for same-day discharge after video-assisted thoracoscopic surgery lung resection: Methodological considerations from the VALUE trial
  29. Correction: Robotic thymectomy for large thymomas: a multicenter study
  30. Pleurectomy/Decortication Versus Extrapleural Pneumonectomy in Pleural Mesothelioma: A Systematic Review and Meta-Analysis of Survival, Mortality, and Surgical Trends
  31. 10-Year Long-Term Outcomes of Robotic-Assisted Segmentectomy for Early-Stage Non-Small-Cell Lung Cancer
  32. Small Nodules and Big Questions: A Closer Look at the RELIANT Trial
  33. Sex Differences in Health-Related Quality of Life Following Pulmonary Resection: A Systematic Review
  34. 10-Year Long-Term Outcomes of Robotic-Assisted Segmentectomy for Early-Stage Non-Small-Cell Lung Cancer
  35. Impact of Surgical extent on survival in pulmonary typical carcinoids: a retrospective analysis
  36. Robotic thymectomy for large thymomas: a multicenter study
  37. “Vetus Sed Utilis”: Open Window Thoracostomy after Lung Surgery
  38. Reflections on the ThoRN Consensus: Toward a Multidisciplinary Integration
  39. Research progress on lung cancer complicated with pulmonary tuberculosis: a narrative review
  40. Surgical Outcomes After Neoadjuvant Chemo-Immunotherapy for Stage III NSCLC: A Systematic Review and Meta-Analysis
  41. The Short-Term Impact of Neoadjuvant Chemotherapy on the Outcome of Patients Undergoing Pneumonectomy for Lung Cancer: Is It Acceptable Nowadays?
  42. Identification and validation of diagnostic alternative splicing events in tumor-educated platelets for non-small cell lung cancer in patients with ground-glass opacity: a multicenter study
  43. Multidisciplinary international expert consensus on perioperative airway management
  44. Redefining resectability: Bridging perspectives in stage III NSCLC management
  45. The Actual Role of CPET in Predicting Postoperative Morbidity and Mortality of Patients Undergoing Pneumonectomy
  46. Unmasking the mimic: lipoid pneumonia imitating primary lung cancer - a case report series of a diagnostic challenge
  47. Unlocking the depths: the evolution of robotic-assisted bronchoscopy
  48. Surgeon preferences for self-treatment in locally advanced non–small cell lung cancer: Would we practice what we preach?
  49. Diverging trends in lung cancer: a 26-year analysis of sex-specific patterns and histological shifts in Northern Italy
  50. Raising the bar: evaluating quality and consistency in clinical guidelines for surgical management of pulmonary carcinoid
  51. The impact of SMARCA4 loss in non-small cell lung cancer therapy
  52. Anatomical Versus Non-Anatomical Pulmonary Metastasectomy: A European Multicentre Propensity Score-Matched Analysis
  53. T4-non-small cell lung cancer invading the thoracic aorta: the role of the hybrid operating room
  54. Lobectomy or Sublobar Resection? Evidence-Based and AI-Enhanced Strategies for Early-Stage Non-Small Cell Lung Cancer
  55. Immune Escape Mechanisms in Non-Small Cell Lung Cancer: From Biological Complexity to Actionable Targets
  56. The Role of Incentive Spirometry in Enhanced Recovery After Lung Cancer Resection: A Propensity Score-Matched Study
  57. Development of an AI model for predicting hypoxia status and prognosis in non-small cell lung cancer using multi-modal data
  58. Physics at the Cutting Edge: The Essential Science Behind Thoracic Surgery
  59. Predictive and prognostic factors in patients with anaplastic lymphoma kinase rearranged early-stage lung adenocarcinoma
  60. Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes
  61. Correction: Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT)
  62. Correction: Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT) (Preprint)
  63. Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT)
  64. Optimal planning and management strategies for minimally invasive lung segmentectomies: an international Delphi consensus report
  65. Safety and Efficacy of Salvage Surgery after Treatment With Immune‐Checkpoint Adjuvant Inhibitors for Advanced Non‐Small Cell Lung Cancer: A Multicentric Study
  66. Harnessing artificial intelligence for breakthroughs in lung cancer management: are we ready for the future?
  67. 1000 Robotic-assisted lobectomies for primary lung cancer: 16 years single center experience
  68. Have lunar cycles and zodiac signs an impact on the mortality and morbidity of the lung cancer surgery?
  69. The Role of Adjuvant Chemotherapy in pN1 (IIB/IIIA) NSCLC Patients Who Undergo Pneumonectomy: Is It Still Justified in the Modern Era?
  70. Revamping Non-Small Cell Lung Cancer Treatments in Stages II and III: Preparing Healthcare for Cutting-Edge Immuno-Oncology Regimens
  71. Bridging the divide: addressing discrepancies between clinical guidelines, policy guidelines, and biomarker utilization
  72. A Multicenter Retrospective Case-Control Study on Simple vs Extended Sleeve Lobectomies
  73. Artificial intelligence in lung cancer
  74. Pneumonectomy for broncho-pulmonary carcinoids: a single centre analysis of surgical approaches and patient outcomes
  75. How General and Inflammatory Status Impacts on the Prognosis of Patients Affected by Lung Cancer: State of the Art
  76. Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration
  77. Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaboration
  78. Cardiopulmonary Resuscitation Training and Automatic External Defibrillators Deployment: Strengthening Community Response to Cardiac Arrest
  79. Mastering the maze: navigating prolonged air leak in thoracic surgery
  80. Pulmonary metastasectomy gaining ground in modern thoracic surgery
  81. Prognostic Factors and Clinical Outcomes of Surgical Treatment of Major Thoracic Trauma
  82. Comprehensive Pulmonary Rehabilitation for Patients with Malignant Pleural Mesothelioma: A Feasibility Pilot Study
  83. The Incidence of Winged Scapula after Thoracic Cancer Surgery: A Prospective Cohort Study
  84. Joint ERS/EACTS/ESTS clinical practice guidelines on adults with spontaneous pneumothorax
  85. Joint ERS/EACTS/ESTS clinical practice guidelines on adults with spontaneous pneumothorax
  86. Recent advances in lung cancer research: unravelling the future of treatment
  87. In solid tumors, neoadjuvant or adjuvant immune checkpoint blockade increases treatment-related grade 3 or 4 adverse events
  88. Multicentre retrospective analysis on pulmonary metastasectomy: an European perspective
  89. Bronchopleural Fistula after Lobectomy for Lung Cancer: How to Manage This Life-Threatening Complication Using Both Old and Innovative Solutions
  90. A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives
  91. On the razor's edge: navigating mature experience and the challenges of aging in modern surgery
  92. Advances in lung cancer surgery: the role of segmentectomy in early–stage management
  93. Mediastinal cellulose pack mimicking lung cancer relapsing after lobectomy
  94. Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT) (Preprint)
  95. Outcomes following minimally invasive approaches vs. open extended lobectomy for non-small cell lung cancer: a propensity-matched analysis of the National Cancer Database
  96. Lung cancer in the era of COVID-19
  97. The role of the surgical volume for clinical outcomes in VATS lobectomy for lung cancer: a national large database multicenter analysis
  98. Anastomosis Complications after Bronchoplasty: Incidence, Risk Factors, and Treatment Options Reported by a Referral Cancer Center
  99. Noncontact remote sensing of abnormal blood pressure using a deep neural network: a novel approach for hypertension screening
  100. Chronos, Kairos, and the environmental control against radon
  101. Reply to Condello
  102. Differences in selected postoperative outcomes between simple and complex segmentectomies for lung cancer: A systematic review and meta-analysis
  103. A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials
  104. Correction: Prospective randomized study on the efficacy of three-dimensional reconstructions of bronchovascular structures on preoperative chest CT scan in patients who are candidates for pulmonary segmentectomy surgery: the PATCHES (Prospective rAndo...
  105. Robotic-assisted tracheal resection for adenoid cystic carcinoma with extracorporeal membrane oxygenation support
  106. Prospective randomized study on the efficacy of three-dimensional reconstructions of bronchovascular structures on preoperative chest CT scan in patients who are candidates for pulmonary segmentectomy surgery: the PATCHES (Prospective rAndomized sTudy ...
  107. Predictors, surrogate, and patient-reported outcomes in immunotherapy and salvage surgery for unresectable lung cancer: a single-center retrospective study
  108. The significance of general data protection regulation in the compliant data contribution to the European Society of Thoracic Surgeons database
  109. Real-world survival outcomes of wedge resection versus lobectomy for cT1a/b cN0 cM0 non-small cell lung cancer: a single center retrospective analysis
  110. The Debate on Surgical Volume and Perioperative Outcomes
  111. Assessment of the 90-day mortality risk score after video-assisted thoracoscopic lobectomy in the Italian VATS Group cohort
  112. Surgical Approaches to Pancoast Tumors
  113. Post-resectional bronchopleural fistula: aetiology, clinical management and future perspectives: a narrative review
  114. Diagnostic Performance and Cell Count of EBUS–TBNA Needle Gauges: A Prospective Trial
  115. Next-Generation Lung Cancer Surgery: A Brief Trip into the Future of the Research
  116. Nutritional status in patients with active pulmonary tuberculosis and new nutritional risk screening model for active tuberculosis: a national, multicenter, cross-sectional study in China
  117. The Role of Immunotherapy or Immuno-Chemotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review
  118. Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries
  119. The Role of Surgery in Primary Chest Wall Tumors: Over 20 Years’ Experience in Resection and Reconstruction
  120. Is It Time to Cross the Pillars of Evidence in Favor of Segmentectomies in Early-Stage Non-Small Cell Lung Cancer?
  121. Clinical impact of vaping on cardiopulmonary function and lung cancer development: an update
  122. Editorial: Near-infrared fluorescence guided surgery: State of the evidence from a health technology assessment perspective
  123. An evaluation of the methodological quality of published guidelines for the surgical treatment of pleural mesothelioma
  124. Commentary: The sublobar resections and the difference between a conjecture and a theorem
  125. A prognostic score from a multicentric retrospective analysis of patients affected by sarcoma with metachronous lung metastases undergoing metastasectomy
  126. A Practical Assessment of the Postoperative Management in Lung Cancer Surgery
  127. Prolonged air leak after video-assisted thoracic anatomical pulmonary resections: a clinical predicting model based on data from the Italian VATS group registry, a machine learning approach
  128. Prolonged air leak after lung surgery: prediction, prevention and management
  129. A brief appraisal on the GRADE methodology and the development of recommendations on the management of prolonged air leaks by the PALAS Study Group
  130. Should we use a biophysical approach in the classification and management of air leakage after lung resection?
  131. Artificial Neural Networks in Lung Cancer Research: A Narrative Review
  132. Surgical management of superior sulcus tumors: A twenty-year experience of an oncological high volume referral centre
  133. The Impact of Surgical Experience in VATS Lobectomy on Conversion and Patient Quality of Life: Results from a Comprehensive National Video-Assisted Thoracic Surgical Database
  134. A retrospective validation study of the STUMBL score for emergency department patients with blunt thoracic trauma
  135. Use of anticoagulation reversal therapy in the emergency department: a single-center real-life retrospective study
  136. Commentary: Brutus, Cassius, the Stars, and the Lung Cancer Screening Criteria
  137. Quantum surgery: the quantum mechanics insight beyond the uniportal video-assisted thoracic surgery (VATS) approach
  138. A Framework for the Definition and Interpretation of the Use of Surrogate Endpoints in Interventional Trials’
  139. Minimally Invasive Anatomical Segmentectomy versus Lobectomy in Stage IA Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
  140. A Multicenter Retrospective Cohort Study on Superior Vena Cava Resection in Non-Small-Cell Lung Cancer Surgery
  141. Factors Associated with Early Discharge after Thoracoscopic Lobectomy: Results from the Italian VATS Group Registry
  142. ARDS after Pneumonectomy: How to Prevent It? Development of a Nomogram to Predict the Risk of ARDS after Pneumonectomy for Lung Cancer
  143. Author Correction: AGREE-S: AGREE II extension for surgical interventions: appraisal instrument
  144. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries
  145. Surgical results of non-small cell lung cancer involving the heart and great vessels
  146. How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?
  147. Correction to: Cover always the bronchial stump! A flap could prevent catastrophic complications even in complete broncho‑pleural fistula
  148. Long-term clinical outcomes and prognostic factors of upfront surgery as a first-line therapy in biopsy-proven clinical N2 non-small cell lung cancer
  149. The Interdisciplinary Management of Lung Cancer in the European Community
  150. The “Balloon-Like” Sign: Differential Diagnosis between Postoperative Air Leak and Residual Pleural Space: Radiological Findings and Clinical Implications of the Young–Laplace Equation
  151. In EBUS Signo Vinces: New Indications in Thoracic Oncology for Mediastinal Lymph Node Staging Using Endobronchial Ultrasound
  152. Impact of the extent of lung resection on postoperative outcomes of pulmonary metastasectomy for colorectal cancer metastases: an exploratory systematic review
  153. The extent of mediastinal lymph node dissection correlates with survival of small cell lung cancer patients after resection: a propensity score-matched cohort study analysis
  154. Cover always the bronchial stump! A flap could prevent catastrophic complications even in complete broncho-pleural fistula
  155. Editorial: Bench Research Behind Lung Cancer Surgery
  156. AGREE-S: AGREE II extension for surgical interventions: appraisal instrument
  157. Commentary: Nothing but a toothbrush for beginning the reduction of the postoperative costs in thoracic surgery
  158. Corrigendum to ‘128P Surgical management of lung metastases: A work-in-progress report from an international ESTS research group’ Annals of Oncology Volume 33 Supplement 2 (2022) S91-S92
  159. The COVID-19 repercussion on Google Trend data analyses
  160. AGREE‐S: AGREE II extension for surgical interventions – United European Gastroenterology and European Association for Endoscopic Surgery methodological guide
  161. Clinical characteristics, surgical treatments, prognosis, and prognostic factors of primary tracheal cancer patients: 20-year data of the National Cancer Center, China
  162. If a Single Swallow Does Not Make a Summer, 10 Patients Do Not Make an Alternative
  163. Risk models to predict outcomes following lung cancer surgery: where are we at?
  164. Climatic factors influence on emergency department visits
  165. Analysis of Molecular Biomarkers in Resected Early-Stage Non-Small Cells Lung Cancer: A Narrative Review
  166. Pneumonectomy and broncho-pleural fistula: predicting factors and stratification of the risk
  167. A Delphi Consensus report from the "Prolonged Air Leak: A Survey" study group on prevention and management of postoperative air leaks after minimally invasive anatomical resections
  168. Long term results of surgery for NSCLC and aortic invasion. A multicenter retrospective cohort study
  169. 128P Surgical management of lung metastases: A work-in-progress report from an international ESTS research group
  170. Outcomes of patients discharged home with a chest tube after lung resection: a multicentre cohort study
  171. Lung cancer stage distribution from before COVID-19 through 18 months of the pandemic: the experience of a large-volume oncological referral centre
  172. Comment on The Unbearable Lightness of Difference Between Statistical and Clinical Significance
  173. Applications of artificial intelligence to prognostic stratification of COVID-19: a narrative review
  174. Multimodal therapy for synchronous bone oligometastatic NSCLC: The role of surgery
  175. Commentary: Go with the flow: The biophysical aspects of tracheal reconstructions
  176. Expert consensus on perioperative immunotherapy in non-small cell lung cancer: an editorial
  177. Commentary: We must constantly look at things in different ways
  178. Should we distinguish between intra and extrapericardial pulmonary artery involvement in NSCLC? A multicenter retrospective case-control study
  179. A proposal for a postoperative protocol for the early diagnosis of bronchopleural fistula after lung resection surgery
  180. THE COVID-19 REPERCUSSION ON TELEMEDICINE: A GOOGLE TREND DATA ANALYSIS
  181. MA01.03 PREC Multicentre Restrospective Study: A Preoperative Risk Classification for Synchronous Oligometastatic Non-Small Cell Lung Cancer
  182. A methodological quality evaluation of the published guidelines and recommendations about the lung cancer screening
  183. Mathematical Analysis of Relationships Between Airflows and Intrapleural Pressures After Video-Assisted Lobectomies>
  184. Google Trend Data Analysis of COVID-19 Repercussion on Lung Cancer Awareness in Italy
  185. Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study
  186. SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study
  187. Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis
  188. Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study
  189. Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)
  190. Safety Analysis of Salvage Surgery for Advanced Stages or Metastatic Lung Cancers
  191. Clinical prognostic factors in surgically treated oligometastatic non-small cell lung cancer: a systematic review
  192. Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis
  193. The importance of being solid for a ground glass opacity of the lung
  194. Outcomes and Safety Analysis in Superior Vena Cava Resection for Extended Thymic Epithelial Tumors
  195. The land of the Lotus-eaters in the COVID-19 epidemic
  196. Post-operative outcomes and quality of life assessment after thoracoscopic lobectomy for Non-small-cell lung cancer in octogenarians: Analysis from a national database
  197. In early stage thymoma the tumor should be resected along with the complete thymus gland
  198. Veno-venous extra-corporeal membrane oxygenation-assisted right tracheal-sleeve pneumonectomy
  199. Work in progress report of a multicentre retrospective observational study to evaluate the association between the airflows and the intrapleural pressures digitally recorded after video-assisted lobectomy
  200. Autologous Blood Pleurodesis: What Is the Optimal Time Interval and Amount of Blood?
  201. A risk stratification scheme for synchronous oligometastatic non-small cell lung cancer developed by a multicentre analysis
  202. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
  203. Timing of surgery following SARS-CoV-2 infection
  204. Paying Another Tribute to the COVID-19 Pandemic: The Decrease of Early Lung Cancers
  205. Role of genomics and histology diagnosis in recurrent malignant pleural effusion
  206. The Weekday Effect on Morbidity of Lung Cancer Surgery: A Real-World Analysis
  207. Contrast-enhanced computed tomography prior to percutaneous transthoracic needle biopsy reduces the incidence of hemorrhage
  208. Predicting a Prolonged Air Leak After Video-Assisted Thoracic Surgery, Is It Really Possible?
  209. The role of pneumonectomy in thoracic surgery in the third millennium
  210. Anatomical segmentectomy versus pulmonary lobectomy for stage I non-small-cell lung cancer: patients selection and outcomes from the European Society of Thoracic Surgeons database analysis
  211. A methodological evaluation of the published consensus statements, recommendations and guidelines about surgical management in the course of coronavirus disease pandemic
  212. Commentary: We are in the same minimally invasive boat, and we have to row in the same direction
  213. Thoracic Surgical Oncology in Lombardy: How to Do It During COVID-19 Time?
  214. Euclidean Geometry Versus Metabolic Biochemistry in the Prognostic Evaluation of Thymic Epithelial Tumors
  215. Age and Clinical Presentation for Primary Spontaneous Pneumothorax
  216. Synchronous Robot-Assisted Pulmonary and Urologic Resections for Cancer
  217. Non-intubated thoracoscopic lobectomies for lung cancer: an exploratory systematic review and meta-analysis
  218. Safety Analysis of Superior Vena Cava Resection for Extended Thymic Epithelial Neoplasms>
  219. Preliminary Results of Extracorporeal Membrane Oxygenation Assisted Tracheal Sleeve Pneumonectomy for Cancer
  220. Opening and closing the doors of the lockdown in Italy without forgetting lung cancer patients
  221. Sialadenoma Papilliferum of the Bronchus: A Rare Tumour of Salivary Gland Origin
  222. Reorganization of thoracic surgery activity in a national high-volume comprehensive cancer centre in the Italian epicentre of coronavirus disease 2019
  223. Don’t get your wires crossed: epicardial wire-induced lung granuloma
  224. Should We Use the Olympic Spirit in the Controversy Between Surgery and Stereotactic Ablative Radiotherapy in Operable Early-Stage Non-Small Cell Lung Cancer?
  225. Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe
  226. Treatment of Chylothorax after Lung Resection: Indications, Timing, and Outcomes
  227. The synthesis of scientific shreds of evidence: a critical appraisal on systematic review and meta-analysis methodology
  228. Appropriate treatment approaches and prognosis of pleural mesothelioma
  229. The hearth of mathematical and statistical modelling during the Coronavirus pandemic
  230. Salvage pneumonectomy after definitive chemo-radiotherapy
  231. Management of medical complications after pneumonectomy
  232. Lung cancer surgery in oligometastatic patients: outcome and survival
  233. Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines
  234. Diagnosis and Treatment of Early and Locally Advanced Non-Small-Cell Lung Cancer: The 2019 AIOM (Italian Association of Medical Oncology) Clinical Practice Guidelines
  235. Surgical Techniques for Chest Wall Diseases
  236. Approaches and Surgical Techniques for Chest Wall Trauma
  237. Minimally Invasive Pulmonary Resections Techniques—Nonanatomical Pulmonary Resections
  238. Epidemiology and management of primary spontaneous pneumothorax: a systematic review
  239. International expert consensus on the management of bleeding during VATS lung surgery
  240. International Delphi survey of the ESTS/AATS/ISTH task force on venous thromboembolism prophylaxis in thoracic surgery: the role of extended post-discharge prophylaxis
  241. Immunotherapy in the neoadjuvant settings: a new challenge for the thoracic surgeon?
  242. Commentary: The power (under control) of meta-analysis in the synthesis of clinical knowledge
  243. Health-related quality of life in lung cancer patients: validation of a national version of EORTC QLQ-LC29 questionnaire
  244. Starting a uniportal VATS program - The Bonn experience
  245. Devising the guidelines: the techniques of uniportal video-assisted thoracic surgery—postoperative management and enhanced recovery after surgery
  246. Methodology and timing of standardization
  247. The radical approach to the oligometastatic not small cell lung cancer patient: which? how? when? where?
  248. What is the European Society of Thoracic Surgeons (ESTS) Uniportal VATS Interest Group (UVIG)?
  249. Corrigendum to ‘Uniportal video-assisted thoracic surgery lobectomy: a consensus report from the Uniportal VATS Interest Group (UVIG) of the European Society of Thoracic Surgeons (ESTS)’  [Eur J Cardiothorac Surg 2019;56:224–9]
  250. Corrigendum to ‘What counts more: the patient, the surgical technique, or the hospital? A multivariable analysis of factors affecting perioperative complications of pulmonary lobectomy by video-assisted thoracoscopic surgery from a large nationwide reg...
  251. Reply to Migliore and Hirai
  252. Urgent lung transplantation in acute fibrinous and organizing pneumonia: a sliding door or a new perspective?
  253. Venous thromboembolism prophylaxis in thoracic surgery patients: an international survey
  254. Uniportal and three-portal video-assisted thoracic surgery lobectomy: analysis of the Italian video-assisted thoracic surgery group database
  255. Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM)
  256. Climbing the slope of the learning curve in the subxiphoid uniportal video-assisted thoracic surgery approach
  257. Endoscopic thoracic sympathectomy or sympathicotomy versus clipping in the surgical management of primary hyperhidrosis: a systematic review and meta-analysis
  258. What counts more: the patient, the surgical technique, or the hospital? A multivariable analysis of factors affecting perioperative complications of pulmonary lobectomy by video-assisted thoracoscopic surgery from a large nationwide registry
  259. Correction to: Risk factors and impact of conversion from VATS to open lobectomy: analysis from a national database
  260. Good-hearted people, Busca cardio-protected city: an evidence-based public access defibrillation project
  261. Uniportal video-assisted thoracic surgery lobectomy: a consensus report from the Uniportal VATS Interest Group (UVIG) of the European Society of Thoracic Surgeons (ESTS)
  262. Conversion due to vascular injury during video-assisted thoracic surgery lobectomy: A multicentre retrospective analysis from the Italian video-assisted thoracic surgery group registry
  263. A comparison of EGFR mutation status in tissue and plasma cell-free DNA detected by ADx-ARMS in advanced lung adenocarcinoma patients
  264. Magnetic anchoring guidance system for video-assisted thoracic surgery: the 2018 update
  265. Bioptic verification of mediastinal lymphoma relapses suspected on the basis of FDG-PET SCAN
  266. Extra-pleural pneumonectomy
  267. The relativity of operative time on the outcomes of the video-assisted thoracoscopic lobectomies
  268. Tubeless thoracic surgery: ready for prime time?
  269. Approaches to the thoracic cavities
  270. NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives
  271. History and development of minimally invasive surgery: VATS surgery
  272. Risk factors and impact of conversion from VATS to open lobectomy: analysis from a national database
  273. Geometric Considerations in Uniportal VATS
  274. Bleeding control during VATS major lung resection without conversion: safe and feasible?
  275. Is the video-assisted pulmonary segmentectomy the preferred approach to the early stage non-small cell lung cancer?
  276. Vascular injuries during VATS lobectomies: keep calm, compress and have a plan
  277. How to teach uniportal VATS to younger and elder generations: two different methods or any common overlapping points?
  278. Surgical approaches to video-assisted thoracic surgery lobectomy: a brief preface
  279. Left VATS Upper Lobectomy
  280. The “loop” technique for primary spontaneous pneumothorax: a retrospective study of 18 patients
  281. How to create a surgical database?
  282. Surgical approaches for extrapleural pneumonectomy for mesothelioma: the lower door thoracotomy
  283. Bronchoscopic management of prolonged air leak
  284. Focus on specific disease-part 2: the European Society of Thoracic Surgery chest wall database
  285. Surgical and endoscopic treatment for COPD: patients selection, techniques and results
  286. P1.14-01 Current Practices in the Management of Malignant Pericardial Effusions: A Survey Amongst Members of the European Society of Thoracic Surgeons
  287. Risk-Adjusted Costs Analysis of a Multicenter Video-Assisted Thoracoscopic Lobectomy Activity
  288. High-resolution computed tomography in the management of the first episode of primary spontaneous pneumothorax: are we sure that more is better?
  289. Systematic Review and Meta-Analysis of Endoscopic Lung Volume Reduction Using Endobronchial Valves in Severe Emphysema: Are They Better?
  290. Multicentre Validation of a Prediction Score of Prolonged Air Leak for VATS Lobectomies
  291. Virtual simulation and learning new skills in video-assisted thoracic surgery
  292. The forest of methodology and the writing of evidence-based medicine papers
  293. Non-intubated awake uniportal VATS: how to start?
  294. Fat but fit for the improved survival in lung cancer surgery
  295. Pathophysiological mechanism of post-lobectomy air leaks
  296. A project to assess the quality of the published guidelines for managing primary spontaneous pneumothorax from the Italian Society of Thoracic Surgeons
  297. Four arms robotic-assisted pulmonary resection—left upper lobectomy: how to do it
  298. The state of the art of the minimally invasive thoracic surgery in Italy
  299. Diagnostic performance of fluorine-18 fluorodeoxyglucose positron emission tomography in the management of solitary pulmonary nodule: a meta-analysis
  300. Robotic internal mammary lymphadenectomy: another possible minimally invasive approach to sampling lymph nodes in breast cancer patients
  301. Safety of lymphadenectomy during video-assisted thoracic surgery lobectomy: analysis from a national database†
  302. Enhanced Recovery After Surgery (ERAS®) in thoracic surgical oncology
  303. 2016 Annual report from the Italian VATS Group
  304. Digital chest tomosynthesis: the 2017 updated review of an emerging application
  305. Enhanced recovery after surgery and video-assisted thoracic surgery lobectomy: the Italian VATS Group* surgical protocol
  306. Enhanced recovery after surgery protocols in video-assisted thoracic surgery lobectomies: the best is yet still to come?
  307. Lung Cancer Update 2017: from the test tube to the bed
  308. Surgical approach in oligometastatic non-small cell lung cancer
  309. The surgeon thunderbolts in 2016 lung cancer literature
  310. COUNTERPOINT: Should Segmentectomy Rather Than Lobectomy Be the Operation of Choice for Early-Stage Non-small Cell Lung Cancer? No
  311. Rebuttal From Drs Bertolaccini and Solli
  312. Robotic surgery, video-assisted thoracic surgery, and open surgery for early stage lung cancer: comparison of costs and outcomes at a single institute
  313. Uniportal non-intubated thoracic surgery
  314. The Very Experienced Time-honoUred Surgeons (VETUS) project
  315. Diaphragmatic and pericardial reconstruction after surgery for malignant pleural mesothelioma
  316. Four arms robotic-assisted pulmonary resection—right lower/middle lobectomy: how to do it
  317. National adoption of video-assisted thoracoscopic surgery (VATS) lobectomy: the Italian VATS register evaluation
  318. Surgical approaches in patients with oligometastatic non-small cell lung cancer
  319. The everlasting story of malignant pleural mesothelioma: where do we stand?
  320. Good–hearted people, Busca cardio protected city: a community of a city in the north-west of Italy involved in a public access defibrillation project
  321. Pros-cons debate about the role and evolution of uniportal video-assisted thoracic surgery (VATS)
  322. Results in video-assisted thoracic surgery for lung cancer
  323. The science behind thoracic surgery: a brief preface
  324. VATS thymectomy: oncological results and comparison between minimally invasive strategies
  325. Video-assisted thoracoscopic surgery (VATS) segmentectomy
  326. Can a standardised Ventilation Mechanical Test for quantitative intraoperative air leak grading reduce the length of hospital stay after video-assisted thoracoscopic surgery lobectomy?
  327. Cost-effectiveness analysis of sealant impact in management of moderate intraoperative alveolar air leaks during video-assisted thoracoscopic surgery lobectomy: a multicentre randomised controlled trial
  328. Thoracoscopic lobectomy for locally advanced-stage non-small cell lung cancer is a feasible and safe approach: analysis from multi-institutional national database
  329. Surgical treatment of synchronous multiple neuroendocrine lung tumours (case series): is more always better?
  330. The Geometric and Ergonomic Appeal of Uniportal Video-Assisted Thoracic Surgery
  331. Molecular analysis driven video-assisted thoracic surgery resections in bilateral synchronous lung cancers: from the test tube to the operatory room
  332. Case management: an up-to-date review of literature and a proposal of a county utilization
  333. Chondroblastoma of the rib in a 47-year-old man: a case report with a systematic review of literature
  334. Erratum to nodal management and upstaging of disease: initial results from the Italian VATS Lobectomy Registry
  335. The biostatistical minimum
  336. Uniportal video-assisted thoracoscopic surgery in hemothorax
  337. Awake non-intubated thoracic surgery: an attempt of systematic review and meta-analysis
  338. Uniportal video assisted thoracic surgery: hilar dissection
  339. Preliminary Data about Quality Check Evaluation of Italian VATS Group Database
  340. Bayesian Analysis of VATS Lobectomy Expertise in Two Thoracic Surgery Units
  341. Four arm robotic-assisted pulmonary resection-right upper lobectomy: how to do it
  342. A Risk Stratification Model for Postoperative Complications following Video-Assisted Thoracic Surgery Lobectomy
  343. Diaphragmatic flap for primary repair in thoracic esophagectomy anastomotic leak
  344. Less is more: lung-sparing direct repair of a traumatic rupture of the bronchus intermedius
  345. Uniportal video-assisted thoracic surgery for pneumothorax and blebs/bullae
  346. Standardized uptake value and radiological density attenuation as predictive and prognostic factors in patients with solitary pulmonary nodules: our experience on 1,592 patients
  347. Nodal management and upstaging of disease: initial results from the Italian VATS Lobectomy Registry
  348. Intentional Segmentectomies for Stage I Lung Cancer: An Up-to-Date Systematic Review
  349. Four arms robotic-assisted pulmonary resection—left lower lobectomy: how to do it
  350. Segmentectomy versus lobectomy for stage I non-small cell lung cancer: a systematic review and meta-analysis
  351. Video-assisted thoracoscopic surgery en bloc chest wall resection
  352. Pulmonary nodules in African migrants caused by chronic schistosomiasis
  353. Uniportal video-assisted thoracic surgery in the diagnosis of mediastinal lymphadenopathy of unknown aetiology
  354. Comparison of digital tomosynthesis and computed tomography for lung nodule detection in SOS screening program
  355. A benchmarking project on the quality of previous guidelines about the management of malignant pleural effusion from the European Society of Thoracic Surgeons (ESTS) Pleural Diseases Working Group
  356. An overview of the use of artificial neural networks in lung cancer research
  357. Pleural pressure theory revisited: a role for capillary equilibrium
  358. Subxiphoid video-assisted major lung resections: the Believers’ speech
  359. Tips and tricks of the propensity score methods in the thoracic surgery research
  360. Video-assisted thoracoscopic surgery bronchial sleeve lobectomy
  361. Technological advancements in thoracic surgery: a brief introduction to the future
  362. Video-assisted thoracic surgery for extended lung cancer disease: moving into the borderlands
  363. VATS: the age of maturity
  364. Biportal VATS approach in the treatment of penetrating thoracic trauma: a case report
  365. Magnetic anchoring guidance system in video-assisted thoracic surgery
  366. Indwelling Pleural Catheters
  367. The pulmonary nodule “discovered” by pneumonia: a case report
  368. Transthoracic needle aspiration in solitary pulmonary nodule
  369. Thoracic surgeons, mathematics, and statisticians: a new multidisciplinary team?
  370. Learning curve and established phase for uniportal VATS lobectomies: the Papworth experience
  371. Right side lobectomies
  372. Reconstructive techniques after diaphragm resection and use of the diaphragmatic flap in thoracic surgery
  373. VATS anatomic resections for lung cancer: insights from the Italian VATS Group
  374. Current practices in the management of malignant pleural effusions: a survey among members of the European Society of Thoracic Surgeons
  375. Robot-assisted lobectomy for lung cancer in the presence of intraoperatively discovered broncho-vascular anomalies affecting right upper and middle lobes
  376. Uniportal video-thoracoscopic mediastinal lymphadenectomy
  377. Surgical case description
  378. Dissection station 2 and 4 on the right hemithorax
  379. Nanos gigantium humeris insidentes: the awarded Cox proportional hazards model
  380. A bird in the hand is worth two in the bush: the choice of localization technique for non-palpable solitary pulmonary nodule
  381. Radioguided VATS resections of subcentimetric solitary pulmonary nodule/ground glass opacity:
  382. Revision of descriptors in forthcoming VIII edition of TNM classification of lung cancer: A single center validation study
  383. Enhanced recovery in thoracic surgery: A propensity-score matched cohort study
  384. Outpatient management of malignant pleural effusion in patients unfit for pleurodesis
  385. Study designs in thoracic surgery research
  386. P-197FEASIBILITY OF MAJOR LUNG RESECTIONS IN THE ELDERLY PATIENTS: A MORBIDITY RISK STRATIFICATION MODEL
  387. Bronchial reacutization and gastroesophageal reflux: is there a potential clinical correlation?
  388. Fiberoptic bronchoscopy for the detection of the gastric pepsin (Pep-test)
  389. Lymph Node Involvement in Deep Infiltrating Intestinal Endometriosis: Does It Really Mean Anything?
  390. Are the fallacies of the P value finally ended?
  391. Lymphnodal micrometastases in NSCLC: where do we stand?
  392. Open repair of pectus carinatum
  393. Management of malignant pleural effusions in patients with trapped lung with indwelling pleural catheter: how to do it
  394. Why should we prefer the single port access thoracic surgery?
  395. Geometric and ergonomic characteristics of the uniportal video-assisted thoracoscopic surgery (VATS) approach
  396. Preoperative predictive value of 18FDG CT/PET tumor metabolic parameters & SUV lymh nodes/tumor ratio in NSCLC
  397. EBUS TBNA negative lymph nodes risk stratification model: A tool for multidisciplinary team
  398. Safety and advantages of VATS biopsy in diagnosis of interstitial lung disease
  399. 165P * PREOPERATIVE POSITRON EMISSION TOMOGRAPHY FRACTAL BIOPSY OF THYMIC EPITHELIAL NEOPLASM
  400. The Importance of Being Solid or Partially Solid for a Solitary Pulmonary Nodule
  401. Spread patterns and effectiveness for surgery after ultrasound-guided rectus sheath block in adult day-case patients scheduled for umbilical hernia repair
  402. Ergon-trial: ergonomic evaluation of single-port access versus three-port access video-assisted thoracic surgery
  403. Oligometastatic Non-Small Cell Lung Cancer: The Pivotal Role of Nodal Status
  404. What is the role of lymph nodal metastases and lymphadenectomy in the surgical treatment and prognosis of thymic carcinomas and carcinoids?: Table 1:
  405. The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors
  406. The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the N and M Components for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors
  407. The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the T component for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors
  408. To Seed or Not to Seed
  409. Analysis of spontaneous pneumothorax in the city of Cuneo: environmental correlations with meteorological and air pollutant variables
  410. Is a positron emission tomography–computed tomography scan useful in the staging of thymic epithelial neoplasms?: Table 1:
  411. 18-Fluorine fluorodeoxyglucose positron emission tomography in the pretreatment evaluation of thymic epithelial neoplasms: a metabolic biopsy confirmed by Ki-67 expression
  412. Radiofrequency ablation for stage I non-small-cell lung cancer in the functionally inoperable patient
  413. 18Fluorine-fluorodeoxyglucose positron emission tomography/computed tomography total glycolytic volume in thymic epithelial neoplasms evaluation: a reproducible image biomarker
  414. Transaxillary access to aortopulmonary window and paraaortic nodes
  415. The IASLC/ITMIG Thymic Malignancies Staging Project: Development of a Stage Classification for Thymic Malignancies
  416. Is lung cancer screening possible with digital chest tomosynthesis?
  417. Results of Li-Tho trial: a prospective randomized study on effectiveness of LigaSure(R) in lung resections
  418. Lung Cancer Detection with Digital Chest Tomosynthesis: Baseline Results from the Observational Study SOS
  419. Deep Impact of Ultrasound in the Intensive Care Unit
  420. Correlation sometimes implies causation: possible roles of correlation analysis between 18fluorine-fluorodeoxyglucose positron emission tomography/computed tomography and thymic epithelial neoplasms
  421. Thymoma and the increased risk of developing extrathymic malignancies: a multicentre study†
  422. Home-management of malignant pleural effusion with an indwelling pleural catheter: Ten years experience
  423. Contribution of β-adrenergic receptors to exercise-induced bronchodilatation in healthy humans
  424. Deep Impact of Ultrasound in the Intensive Care Unit
  425. The relationship between meteorological variations and the onset of spontaneous pneumothorax
  426. Surgery for the treatment of the tuberculosis-destroyed lung: to protect or not to protect the bronchial stump?
  427. Not palpable? Role of radio-guided video-assisted thoracic surgery for nonpalpable solitary pulmonary nodules
  428. It sometimes happens: late tracheal rupture after total thyroidectomy
  429. Risk is not our business: safety of thoracic surgery in patients using antiplatelet therapy
  430. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms
  431. eComment: The Six Sigma approach: from mobile phones to chest tubes
  432. eComment: The evaluation of sample size: vice and virtue of statistics?
  433. eComment: About the localization techniques of solitary pulmonary nodules
  434. The standardize uptake value: light and shade of positron emission tomography
  435. ‘Six Sigma approach’ — an objective strategy in digital assessment of postoperative air leaks: a prospective randomised study
  436. Bronchial anastomosis: to wrap or not to wrap?
  437. The sound of silence: the harmonic analysis in thoracic surgery
  438. Treatment of Late Tracheomediastinal Fistula following Diagnostic Mediastinoscopy Treated by Multiple Pedicled Muscle Flaps
  439. Single-port video-assisted thoracic surgery resection: the Copernican revolution of a geometrical approach in thoracic surgery?
  440. 71PD NOT ONLY THE FINGERS: ROLE OF RADIO-GUIDED VIDEO-ASSISTED THORACIC SURGERY IN NON-PALPABLE SOLITARY PULMONARY NODULES
  441. Bronchial Carcinoid Tumours in Children — A Review
  442. A golden key can open any door of new protocol: the use of continuous digital measurement for postoperative air leak
  443. Letter to the editor
  444. Conservative management of cardiac haemangioma
  445. Lung sealant and morbidity after pleural decortication: a prospective randomized, blinded study
  446. Spontaneous Bilateral Pneumothorax in Patient With Previous Thoracoscopic Pleurodesis for Right Recurrent Pneumothorax
  447. Physiology of the Lungs in Microgravity
  448. 153PD MANAGEMENT OF MALIGNANT PLEURAL EFFUSION BY CHRONIC INDWELLING PLEURAL CATHETER
  449. Malignant Pleural Effusions: Review of Treatment and Our Experience
  450. Inguino-scrotal hernia of a double district ureter: case report and literature review
  451. P-807 Outpatient management of malignant pleural effusions
  452. New Approaches in the Management of Septic Shock